ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

232
Analysis
Health Care • Japan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
•21 Aug 2020 17:22

🇯🇵 JAPAN • IT’S A WRAP - Summer 2020 Results & Revisions Review

BRUTAL - The summer earnings 'season' reflected the broadening impact of COVID-19 on the Japanese and world economies, however, in terms of profit...

Logo
351 Views
Share
bearish•Quantitative Analysis
•20 Aug 2020 02:59

Looking at Japan Dividends This Year

The question has been asked about dividends in Japan and what they may look like for the remainder of this year and into 2021. Japanese companies...

Logo
432 Views
Share
•03 Aug 2020 06:31

🇯🇵 JAPAN • Results & Revisions 31st July - Takeda, Yamato/SG, Seria, FP, Keyence, Dai-Ichi Sankyo

CORRECTION - The last day of July saw the TOPIX index fall by 2.8% to reach a new two-month low, 8.2% below the closing high of June 8th. A...

Logo
277 Views
Share
•13 Jul 2020 14:39

🇯🇵 JAPAN • Stress Tests Part 6: Currency Risk

WHAT CURRENCY RISK? - It seems rather old-fashioned to raise the topic of currency risk in relation to potential stressors on Japanese listed...

Logo
328 Views
Share
bullish•Olympus Corp
•25 Jun 2020 16:27

Olympus Finally Sells Its Loss-Making Camera Business

Olympus announced yesterday (24th June) that it will be selling its Imaging business to Japan Industrial Partners (JIP) and the parties are aiming...

Share
x